Markets / Mutual funds / Sectoral / Thematic
DSP Mutual Fund · Equity fund · Regular plan · IDCW
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies/entities. There is no assurance that the investment objective of the Scheme will be achieved.
Bars: this plan; the thin mark is the Sectoral / Thematic average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -0.3 | |||||||||||
| 2025 | -5.2 | -15.7 | +3.6 | -0.3 | +1.5 | +1.6 | +5.6 | -3.7 | -1.9 | +2.6 | +1.8 | -2.0 |
| 2026 | -4.9 | -5.9 | -5.1 | +7.7 | +4.8 | +5.6 | +2.3 | +4.7 | -3.4 | -0.1 | +2.3 |
Each month's change in NAV (the current month to the latest NAV).
Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.
| Share of fund | 30 Sept 2026 | 31 Aug 2026 | Change |
|---|---|---|---|
| Stocks held | 84.0% | 87.9% | -3.95 |
| Short positions | -0.1% | -0.9% | +0.82 |
| Cash & others | 16.1% | 12.1% | +3.95 |
| Top 10 stocks | 57.4% | 59.7% | -2.30 |
| Number of stocks | 27 | 26 | +1 |
Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.
| Holding | % of fund |
|---|---|
| IPCA Laboratories Limited INE571A01038 | 8.13% |
| Sun Pharmaceutical Industries Limited INE044A01036 | 7.44% |
| Cipla Limited INE059A01026 | 7.18% |
| Sai Life Sciences Limited INE570L01029 | 6.52% |
| Gland Pharma Limited INE068V01023 | 6.15% |
| Apollo Hospitals Enterprise Limited INE437A01024 | 6.07% |
| Alkem Laboratories Limited INE540L01014 | 4.75% |
| Divi's Laboratories Limited INE361B01024 | 4.17% |
| Cohance Lifesciences Limited INE03QK01018 | 3.79% |
| Alembic Pharmaceuticals Limited INE901L01018 | 3.18% |
| Kovai Medical Center And Hospital Limited INE177F01017 | 2.83% |
| Pfizer Limited INE182A01018 | 2.72% |
| Concord Biotech Limited INE338H01029 | 2.70% |
| Procter & Gamble Health Limited INE199A01012 | 2.36% |
| Vijaya Diagnostic Centre Limited INE043W01024 | 2.36% |
| Indoco Remedies Limited INE873D01024 | 2.26% |
| Thyrocare Technologies Limited INE594H01019 | 1.91% |
| Manipal Health Enterprises Limited INE459N01021 | 1.85% |
| Unichem Laboratories Limited INE351A01035 | 1.64% |
| Syngene International Limited INE398R01022 | 1.35% |
| Nephrocare Health Services Limited INE428V01029 | 1.12% |
| ICICI Lombard General Insurance Co Limited INE765G01017 | 1.02% |
| Aarti Drugs Limited INE767A01016 | 0.98% |
| Eris Lifesciences Limited INE406M01024 | 0.72% |
| Jupiter Life Line Hospitals Limited INE682M01020 | 0.35% |
| Abbott India Limited INE358A01014 | 0.26% |
| Laxmi Dental Limited INE0WO601020 | 0.14% |
| Holding | % of fund |
|---|---|
| Net Receivables/Payables | -0.07% |
| Holding | % of fund |
|---|---|
| TREPS / Reverse Repo Investments | 6.81% |
| Globus Medical Inc US3795772082 | 5.15% |
| Intuitive Surgical Inc US46120E6023 | 1.95% |
| Global X Funds - Global X Genomics & Biotechnology ETF US37960A2143 | 1.10% |
| Abbott Laboratories US0028241000 | 0.80% |
| Grail Inc US3847471014 | 0.31% |
From the fund house's monthly portfolio (dspim.com), as on 30 Sept 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.
Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 31 Dec 2018).
The ranges the fund is allowed to hold, not what it holds today.
| Fund size (average AUM, July - September 2026) | ₹3,721 cr across all plans · this plan ₹14.16 cr |
| Fund house | DSP Mutual Fund |
| Category | Equity · Sectoral / Thematic |
| Plan | Regular |
| Option | IDCW |
| Expense ratio (TER) | Direct 0.76% · Regular 2.05% (5 Nov 2026) |
| Exit load | 0.50% - Holding period from the date of allotment <= 1 month, Nil - Holding period from the date of allotment > 1 month (as a % of Applicable NAV) |
| Minimum investment | ₹100 · additional ₹100 |
| Scheme code (AMFI) | 145453 |
| ISIN | INF740KA1LE6 |
| NAV date | 5 Nov 2026 |
Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.
| Plan | NAV | 1 year |
|---|---|---|
| Direct · Growth | ₹51.1830 | +17.34% |
| Direct · IDCW | ₹29.5980 | +8.08% |
| Regular · Growth | ₹45.5860 | +15.81% |
| Fund | 1 year | 3 years (a year) |
|---|---|---|
| Nippon India Taiwan Equity Fund | +37.70% | +40.44% |
| HDFC Defence Fund | +19.63% | +33.69% |
| HDFC Pharma and Healthcare Fund | +26.81% | +30.17% |
| SBI HEALTHCARE OPPORTUNITIES FUND | +21.11% | +24.39% |
| HDFC Transportation and Logistics Fund | +8.74% | +23.82% |
| UTI - Healthcare Fund | +17.70% | +23.50% |
| Mirae Asset Healthcare Fund | +22.57% | +23.40% |
| BANK OF INDIA MANUFACTURING & INFRASTRUCTURE FUND | +16.15% | +22.19% |
All Sectoral / Thematic funds ranked › · Compare with others ›
Information only, not investment advice.
₹26.4070 as of 5 Nov 2026, from AMFI's official NAV data.
1 year: 6.63%, 3 years: 10.54% a year, 5 years: 5.39% a year
Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.